Tesnatilimab

Tesnatilimab (JNJ-64304500) is a human IgG4 monoclonal antibody targeting NKG2D. Tesnatilimab can be studied in research for diseases such as Crohn’s disease (CD) and Inflammatory Bowel Disease (IBD) . Recommend Isotype Controls: Human IgG4 (S228P) kappa, Isotype Control (HY-P99003) [1].

Product Specifications

CAS Number

[2242758-08-1]

Product Name Alternative

JNJ-64304500; IPH-2301; NN-8555

UNSPSC

12352203

Target

C-type Lectin-like Receptors (CTLRs)

Type

Inhibitory Antibodies

Related Pathways

Immunology/Inflammation

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/tesnatilimab.html

Purity

99.80

Solubility

10 mM in DMSO

Smiles

[Tesnatilimab]

Molecular Weight

(143.9 kDa)

References & Citations

[1]Wei L, et al. The role of NKG2D and its ligands in autoimmune diseases: new targets for immunotherapy[J]. International Journal of Molecular Sciences, 2023, 24 (24) : 17545.